Takeda options programs discovered through Schrodinger alliance
Takeda Pharmaceutical Co. Ltd. and drug discovery firm Schrodinger Inc. penned a multi-year, multi-target deal focused on Takeda’s core therapy areas.
- Digital Health
- Drug Discovery Tools
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.